ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BORIS GUREVICH M.D.

Internal Medicine

55,097

$3.66M

1024
951 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $60

ROBERT FRANKLE M.D.

Internal Medicine

42,865

$2.95M

739
287 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $60

DANIEL BERGER M.D.

Internal Medicine

6,508

$2.93M

189
74 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 25%

$450
Average prescription price

Avg: $60

TIBOR KOPJAS M.D.

Internal Medicine

48,270

$2.91M

1752
1486 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

WARREN PIERCE MD

Internal Medicine

34,109

$2.28M

852
738 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $60

JAROSLAV GOLDMAN M.D.

Internal Medicine

37,739

$2.27M

884
800 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

DHEERAJ MAHAJAN M.D.

Internal Medicine

36,651

$2.04M

809
498 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

JOHN HAEBICH M.D.

Internal Medicine

36,454

$2.02M

691
425 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

SYED HUSSAIN MD.

Internal Medicine

28,298

$1.86M

830
470 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $60

OLGA LANSKY M.D.

Internal Medicine

25,806

$1.86M

654
569 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $60

YASEEN ODEH M.D.

Internal Medicine

26,979

$1.83M

368
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

YAKOV RYABOV MD

Internal Medicine

26,361

$1.75M

561
366 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $60

MORGAN MEYER MD

Internal Medicine

25,604

$1.74M

1130
1061 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

BIKRAMJIT MALHOTRA M.D.

Internal Medicine

35,329

$1.74M

800
629 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

JEFFREY HERSHKOWITZ D.O.

Internal Medicine

21,066

$1.65M

693
565 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $60

LOUIS GARY M.D.

Internal Medicine

25,198

$1.63M

534
419 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $60

JEROME ZWIERZYCKI MD

Internal Medicine

21,989

$1.63M

422
322 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $60

ABRAM STARR M.D.

Internal Medicine

28,684

$1.62M

508
469 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $60

ARTHUR MOSWIN M.D.

Internal Medicine

3,985

$1.61M

93
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 25%

$403
Average prescription price

Avg: $60

MILENKO LAZAREVIC MD

Internal Medicine

24,216

$1.58M

626
469 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $60

CHANDRA ANAND MD

Internal Medicine

22,320

$1.52M

755
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

FARRUKH KUREISHY MD

Internal Medicine

22,203

$1.51M

534
432 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

RAJNIKANT PATEL MD

Internal Medicine

29,371

$1.5M

794
653 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $60

MUHAMMAD KHAN MD

Internal Medicine

28,273

$1.45M

765
670 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $60

VADIM EDELSTEIN M.D.

Internal Medicine

26,100

$1.44M

616
558 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank